RegisterLogin

VPC-18005

CAT: 0804-HY-122234-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-122234-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
VPC-18005 inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain, and disrupts the ERG binding to DNA. VPC-18005 is a potent inhibitor of luciferase activity[1].
CAS Number
[2242480-48-2]
UNSPSC
12352005
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vpc-18005.html
Purity
99.80
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(O)CC(S/C(N1)=N\N=C/C2=CC=C(C(C)C)C=C2)C1=O
Molecular Formula
C15H17N3O3S
Molecular Weight
319.38
References & Citations
[1]Miriam S Butler, et al. Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer. Oncotarget. 2017 Jun 27;8 (26) :42438-42454.|[2]Haneen Amawi, et al. The use of zebrafish model in prostate cancer therapeutic development and discovery. Cancer Chemother Pharmacol. 2021 Mar;87 (3) :311-325.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-118409VPC-3033
HY-116501-01VPC-14449
HY-139970VPC-13789
HY-126076A-01VPC-80051
HY-117669-01VPC-14228
HY-147291-01VPC-70063
HY-144878-01VPC-70619
HY-108490-01VPC 23019
HY-120018-01VPC-13566
HY-126076-01VPC-80051 (racemate)

Alternative Products

CatalogName
MBS3617052-01VPC-18005
MBS3616515-01VPC-13566
MBS3616384-01VPC-14228
T9731-01VPC-70619
MBS5770159VPC 23019
MBS5785987VPC-70063
BA9177-5.1VPC-14449
T68678-01VPC 24191
T204737-01VPC-80051
MBS5812525VPC-16606

Popular Products